BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12861985)

  • 1. Kinases--SMi conference: 9-10 April 2003, London, UK.
    Harrison R
    IDrugs; 2003 Jun; 6(6):560-2. PubMed ID: 12861985
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutathione S-transferase p elicits protection against H2O2-induced cell death via coordinated regulation of stress kinases.
    Yin Z; Ivanov VN; Habelhah H; Tew K; Ronai Z
    Cancer Res; 2000 Aug; 60(15):4053-7. PubMed ID: 10945608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma therapeutics--SMi conference: 31 April-1 May 2003, London, UK.
    Lunec A
    IDrugs; 2003 Jun; 6(6):555-9. PubMed ID: 12861984
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
    Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
    Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA-approved small-molecule kinase inhibitors.
    Wu P; Nielsen TE; Clausen MH
    Trends Pharmacol Sci; 2015 Jul; 36(7):422-39. PubMed ID: 25975227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of lipopolysaccharide-stimulated JNK activity in rat aortic smooth muscle cells by pharmacological and adenovirus-mediated inhibition of inhibitory kappa B kinase signalling.
    MacKenzie CJ; Paul A; Wilson S; de Martin R; Baker AH; Plevin R
    Br J Pharmacol; 2003 Jul; 139(5):1041-9. PubMed ID: 12839879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
    Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
    J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of mitogen-activated protein kinase kinase kinase reversed cAMP inhibition of NF-kappaB in T cells.
    Ho HY; Lee HH; Lai MZ
    Eur J Immunol; 1997 Jan; 27(1):222-6. PubMed ID: 9022022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages.
    Chan ED; Winston BW; Uh ST; Wynes MW; Rose DM; Riches DW
    J Immunol; 1999 Jan; 162(1):415-22. PubMed ID: 9886415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human homolog of the yeast Ssk2/Ssk22 MAP kinase kinase kinases, MTK1, mediates stress-induced activation of the p38 and JNK pathways.
    Takekawa M; Posas F; Saito H
    EMBO J; 1997 Aug; 16(16):4973-82. PubMed ID: 9305639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential activation of mitogen-activated protein kinases by palytoxin and ouabain, two ligands for the Na+,K+-ATPase.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1998 Aug; 151(2):377-84. PubMed ID: 9707514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
    Okumura K; Shirasawa S; Nishioka M; Sasazuki T
    Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RO 31-8220 activates c-Jun N-terminal kinase and glycogen synthase in rat adipocytes and L6 myotubes. Comparison to actions of insulin.
    Standaert ML; Bandyopadhyay G; Antwi EK; Farese RV
    Endocrinology; 1999 May; 140(5):2145-51. PubMed ID: 10218965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
    Lindroos PM; Rice AB; Wang YZ; Bonner JC
    J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
    Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The oncogenic TEL/PDGFR beta fusion protein induces cell death through JNK/SAPK pathway.
    Atfi A; Prunier C; Mazars A; Défachelles AS; Cayre Y; Gespach C; Bourgeade MF
    Oncogene; 1999 Jul; 18(26):3878-85. PubMed ID: 10445851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2.
    Waskiewicz AJ; Flynn A; Proud CG; Cooper JA
    EMBO J; 1997 Apr; 16(8):1909-20. PubMed ID: 9155017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase.
    Salmeron A; Ahmad TB; Carlile GW; Pappin D; Narsimhan RP; Ley SC
    EMBO J; 1996 Feb; 15(4):817-26. PubMed ID: 8631303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.